The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...

Sen. Bernie Sanders has been probing the high prices that Novo charges for Ozempic and Wegovy. Yesterday, he share that ...

Overall, recent studies have shown that GLP-1 drugs have led to a 10-20% reduction in body weight and lowered the risk of heart attack, stroke and cardiovascular death by approximately 20%.

As Novo Nordisk A/S and Eli Lilly and Co. go head-to-head in the U.S. and Chinese glucagon-like peptide-1 receptor agonists (GLP-1RA) market for diabetes and ...

Evidence shows that blockbuster weight-loss medications can reduce obesity even in children aged 6–11, but their long-term ...

We recently compiled a list of the 10 Best Counter Cyclical and Defensive Stocks to Invest In. In this article, we are going ...

NVO stock gains 4.2% after it presents efficacy data superior to Wegovy for its new oral pill, amycretin, in an early-stage ...

The drug manufacturer has developed a pill that could bring about weight loss of as much as 13% in three months, according to ...

ADRs traded higher in the premarket on Wednesday after the Danish drugmaker released full results from an early-stage trial ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with ...

There are currently no pharmaceutical treatments approved for general obesity in under-12s — as opposed to that found with some rare genetic disorders — said Claudia Fox, a professor from University ...